Chemical industry – Page 5
-
BusinessWill oral weight loss drugs challenge injectables?
Pills may offer convenience for manufacturers, but it’s not clear they will overtake existing drugs
-
BusinessThe challenge of developing oral alternatives to peptide weight loss drugs
Companies are racing to develop alternatives to injectable diabetes and weight loss drugs
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps
-
BusinessChemours ordered to immediately limit PFAS emissions into Ohio River
US judge grants injunction to reduce Gen-X discharges from West Virginia plant to permitted levels
-
NewsUS government cancels mRNA vaccine research
Experts fear industrial and academic research may move abroad after infectious disease projects cancelled
-
Opinion‘Creative destruction’ in the chemistry lab
Some obsolete lab equipment is quickly replaced, while other items are stubbornly persistent. What modern tech will survive to the 2060s?
-
BusinessMerck & Co to cut 6000 jobs, Moderna to cut around 500
Both firms aiming to make significant reductions in annual costs by reorganising
-
BusinessDuPont and spin-offs settle with New Jersey over PFAS contamination
Proposed deal with the US state includes $875 million in damages, plus clean-up funds
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
NewsUS EPA accused of skewing soil testing data after East Palestine disaster
Environmental Protection Agency will review decisions made during emergency response
-
ResearchTen years on, pharma industry still testing for implausible alkyl sulfonate ester contaminants
Risk assessment for potential mutagenic side-products is still required by regulatory bodies, despite lack of evidence they form during drug production
-
NewsAs AI-designed drug looks to pass final hurdle, will this tech change drug discovery forever?
AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI’s impact in pharma
-
BusinessSarepta gene therapy deaths highlight tragic rare disease dilemma
Regulators block Duchenne muscular dystrophy treatment after fatal side-effects outweigh questionable efficacy
-
OpinionLosing sleep over pesticide exposure
Managing exposure risks poses questions about the extent of producers’ and regulators’ responsibilities for safety
-
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
News‘I barely sleep for four hours’: Are pesticides robbing farmers worldwide of sleep?
Studies point to an emerging link between a range of pesticides and insomnia
-
NewsChemistry ‘cold spots’ emerging across the UK, RSC warns
Some regions face a future with fewer chemists
-
-
BusinessTwo more European crackers to close
Sabic will not reopen UK plant and Dow will close another in Germany